In summary, this study identified BATF2 as the target gene of miR-939-3p in sarcoma, and revealed that both upregulated miR-939-3p and downregulated BATF2 expression levels were significantly associated with a poor prognosis of sarcoma patients. Here, BATF2 is linked to sarcoma.